Agassi Sports Entertainment appoints Clive G. Brookes to board and committee chair roles

Micron Technology (MU) has paused construction on a $3B-$4.5B chip plant in Taiwan amid labor disputes. Workers demand a 15% share of operating profit, citing Samsung and SK Hynix as benchmarks. Micron's fiscal 2026 revenue was $133.2B with $99.3B in operating income. The company has invested $50B in Taiwan over three decades.

Unilever aims to save $1.62 billion by restructuring its operating model, focusing on personal care segments, and simplifying its portfolio. The company will split into six performance units, with regional presidents leading each. CEO Fernando Fernandez stated the changes will drive growth and efficiency.

Oracle (ORCL) canceled a $7B AI chip leasing deal with Tencent (0700.HK) due to US government concerns and China's push for domestic semiconductors, according to the Financial Times. The 5-year agreement involved 100,000 AI chips in Southeast Asia data centers.

IREN, an AI data center firm, delayed some Microsoft infrastructure deliveries due to design changes, pushing its $4B revenue target timeline. Despite a 17% drop during a broader selloff, IREN beat quarterly revenue estimates with strong AI cloud growth, reporting $228M in revenue. The company plans $15B in spending and has significant contracts with Nvidia and Microsoft.

TG Therapeutics (TGTX) reported initial Phase 1 data for Azer Cel in progressive multiple sclerosis. Analysts have varying expectations for the company's future, focusing on either BRIUMVI or broader autoimmune and cell-therapy developments. The news is context-dependent based on which narrative investors believe.

Perspective Therapeutics (CATX) reported 75% progression-free survival at 18 months in 57 GEP-NET patients expressing SSTR2 in a retrospective analysis. The company aims for an end-of-Phase 2 meeting in Q1 2027 and a Phase 3 start in 2027, pending FDA feedback and completion of required activities.